Wednesday, October 8, 2008 - 4:42AM EST

Stem Cell Transplantation

1. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.

Author
Jabbour E; Cortes J; Kantarjian HM; Giralt S; Jones D; Jones R; Giles F; Andersson BS; Champlin R; de Lima M;
Institution
Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Journal
Blood. 2006 Aug 15;108(4):1421-3. Epub 2006 Apr 6.
Abstract URL
Click here to view abstract

2. Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia.

Author
Heim D; Friess D; Christen S; Stussi G; Meyer-Monard S; Tichelli A; Passweg JR; Gratwohl A;
Institution
Journal
Leukemia. 2006 May;20(5):898-900.

3. Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.

Author
Giralt SA; Arora M; Goldman JM; Lee SJ; Maziarz RT; McCarthy PL; Sobocinski KA; Horowitz MM;
Institution
M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77230, USA. sgiralt@mdanderson.org
Journal
Br J Haematol. 2007 Jun;137(5):461-7. Epub 2007 Apr 24.
Abstract URL
Click here to view abstract

4. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

Author
Savani BN; Rezvani K; Mielke S; Montero A; Kurlander R; Carter CS; Leitman S; Read EJ; Childs R; Barrett AJ;
Institution
Stem Cell Allogeneic Transplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bldg 10, Hatfield CRC, Bethesda, MD 20892-1202, USA.
Journal
Blood. 2006 Feb 15;107(4):1688-95. Epub 2005 Aug 30.
Abstract URL
Click here to view abstract

5. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

Author
Baker KS; Loberiza FR Jr; Yu H; Cairo MS; Bolwell BJ; Bujan-Boza WA; Camitta BM; Garcia JJ; Ho WG; Liesveld JL; Maharaj D; Marks DI; Schultz KR; Wiernik P; Zander AR; Horowitz MM; Keating A; Weisdorf DJ;
Institution
Pediatric Blood and Marrow Transplant Program, University of Minnesota, Mayo Mail Code 484, Minneapolis, MN 55455, USA. baker084@umn.edu
Journal
J Clin Oncol. 2005 Oct 1;23(28):7032-42. Epub 2005 Sep 6.
Abstract URL
Click here to view abstract

6. Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

Author
Crawley C; Szydlo R; Lalancette M; Bacigalupo A; Lange A; Brune M; Juliusson G; Nagler A; Gratwohl A; Passweg J; Komarnicki M; Vitek A; Mayer J; Zander A; Sierra J; Rambaldi A; Ringden O; Niederwieser D; Apperley JF;
Institution
Clinical Haematology, Box 234, Addenbrookes Hospital, Cambridge, CB2 2QQ United Kingdom. charles.crawley@addenbrookes.nhs.uk
Journal
Blood. 2005 Nov 1;106(9):2969-76. Epub 2005 Jul 5.
Abstract URL
Click here to view abstract

7. A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors.

Author
Robin M; Guardiola P; Devergie A; Yeshurun M; Shapiro S; Esperou H; Ribaud P; Rocha V; Gluckman E; Socie G;
Institution
Service d'hematologie--greffe de moelle, Hopital Saint-Louis, APHP, Paris, Cedex, France.
Journal
Leukemia. 2005 Sep;19(9):1613-20.
Abstract URL
Click here to view abstract

8. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia.

Author
Carreras E; Jimenez M; Gomez-Garcia V; de la Camara R; Martin C; Martinez F; Iriondo A; Sanz G; Canizo C; Cabrera R; Sierra J; Vallejo C; Lopez J; Martinez C; Rovira M; Fernandez-Ranada JM; Torres A;
Institution
Spanish Bone Marrow Donor Registry (REDMO), IDIBAPS, Barcelona, Spain. carreras@clinic.ub.es
Journal
Bone Marrow Transplant. 2006 Jan;37(1):33-40.
Abstract URL
Click here to view abstract

9. Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment.

Author
Dazzi F; Fozza C;
Institution
Department of Haematology, Imperial College at Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Journal
Best Pract Res Clin Haematol. 2007 Jun;20(2):311-27.
Abstract URL
Click here to view abstract

10. Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantation.

Author
Huang Q; Wu Y; Snyder DS; Chang KL; Slovak ML; Gaal KK; Palmer JM; Weiss LM;
Institution
Division of Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA.
Journal
Am J Clin Pathol. 2007 Oct;128(4):565-70.
Abstract URL
Click here to view abstract
Pages: 1 2 3